These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12556599)

  • 21. Value for the money spent? Exploring the relationship between expenditures, insurance adequacy, and access to care for publicly insured children.
    Colby MS; Lipson DJ; Turchin SR
    Matern Child Health J; 2012 Apr; 16 Suppl 1():S51-60. PubMed ID: 22476794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in spending for substance abuse treatment, 1986-2003.
    Mark TL; Levit KR; Vandivort-Warren R; Coffey RM; Buck JA;
    Health Aff (Millwood); 2007; 26(4):1118-28. PubMed ID: 17630455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders.
    Clark RE; Samnaliev M; McGovern MP
    Psychiatr Serv; 2009 Jan; 60(1):35-42. PubMed ID: 19114568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mental health expenditures for services for people with severe mental illnesses.
    Hollingsworth EJ; Sweeney JK
    Psychiatr Serv; 1997 Apr; 48(4):485-90. PubMed ID: 9090731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of eliminating behavioral health benefits for selected medicaid enrollees.
    McConnell KJ; Wallace NT; Gallia CA; Smith JA
    Health Serv Res; 2008 Aug; 43(4):1348-65. PubMed ID: 18384360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of copayments on substance abuse treatment expenditures and treatment reoccurrence.
    Lo Sasso AT; Lyons JS
    Psychiatr Serv; 2002 Dec; 53(12):1605-11. PubMed ID: 12461223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Iowa Managed Substance Abuse Care Plan: access, utilization, and expenditures for Medicaid recipients.
    McCarty D; Argeriou M
    J Behav Health Serv Res; 2003; 30(1):18-25. PubMed ID: 12633002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spending on mental and substance use disorders projected to grow more slowly than all health spending through 2020.
    Mark TL; Levit KR; Yee T; Chow CM
    Health Aff (Millwood); 2014 Aug; 33(8):1407-15. PubMed ID: 25092843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in mental health insurance benefits and out-of-pocket spending.
    McKusick DR; Mark TL; King EC; Coffey RM; Genuardi J
    J Ment Health Policy Econ; 2002 Jun; 5(2):71-8. PubMed ID: 12529560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotropic drug use and expenditures among medicaid beneficiaries with and without other mental health or substance abuse services.
    Hennessy KD; Green-Hennessy S; Buck JA; Miller K
    J Nerv Ment Dis; 2003 Jul; 191(7):476-8. PubMed ID: 12891096
    [No Abstract]   [Full Text] [Related]  

  • 31. Utilization of Medicaid mental health services by nondisabled children and adolescents.
    Buck JA
    Psychiatr Serv; 1997 Jan; 48(1):65-70. PubMed ID: 9117502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral health expenditures and state organizational structure.
    Fleming E; Ma CA; McGuire TG
    Adm Policy Ment Health; 2000 Jan; 27(3):91-111. PubMed ID: 10826213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How a managed behavioral health care carve-out plan affected spending for episodes of treatment.
    Huskamp HA
    Psychiatr Serv; 1998 Dec; 49(12):1559-62. PubMed ID: 9856616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment for substance use disorders in a privately insured population under managed care: costs and services use.
    Greenfield SF; Azzone V; Huskamp H; Cuffel B; Croghan T; Goldman W; Frank RG
    J Subst Abuse Treat; 2004 Dec; 27(4):265-75. PubMed ID: 15610828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral health insurance parity for federal employees.
    Goldman HH; Frank RG; Burnam MA; Huskamp HA; Ridgely MS; Normand SL; Young AS; Barry CL; Azzone V; Busch AB; Azrin ST; Moran G; Lichtenstein C; Blasinsky M
    N Engl J Med; 2006 Mar; 354(13):1378-86. PubMed ID: 16571881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic grand rounds: medical expenditures among children with psychiatric disorders in a Medicaid population.
    Mandell DS; Guevara JP; Rostain AL; Hadley TR
    Psychiatr Serv; 2003 Apr; 54(4):465-7. PubMed ID: 12663833
    [No Abstract]   [Full Text] [Related]  

  • 37. Mental Health and Substance-Use Reforms--Milestones Reached, Challenges Ahead.
    Huskamp HA; Iglehart JK
    N Engl J Med; 2016 Aug; 375(7):688-95. PubMed ID: 27532837
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of managed care on access to mental health services among Medicaid enrollees receiving substance treatment.
    Bigelow DA; McFarland BH; McCamant LE; Deck DD; Gabriel RM
    Psychiatr Serv; 2004 Jul; 55(7):775-9. PubMed ID: 15232016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parity and out-of-pocket spending for children with high mental health or substance abuse expenditures.
    Barry CL; Chien AT; Normand SL; Busch AB; Azzone V; Goldman HH; Huskamp HA
    Pediatrics; 2013 Mar; 131(3):e903-11. PubMed ID: 23420919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with high levels of spending for younger dually eligible beneficiaries with mental disorders.
    Frank RG; Epstein AM
    Health Aff (Millwood); 2014 Jun; 33(6):1006-13. PubMed ID: 24889950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.